Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 6.
| Dosage form | NDCs |
|---|---|
| injection | 6 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| fareva | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | BRENTUXIMAB VEDOTIN | injection | 78848-003DRUG FOR FURTHER PROCESSING |
| - | CETRORELIX | injection | 78848-005DRUG FOR FURTHER PROCESSING |
| - | MYCOPHENOLATE MOFETIL | injection | 78848-004DRUG FOR FURTHER PROCESSING |
| - | TEMSIROLIMUS | injection | 78848-002DRUG FOR FURTHER PROCESSING |
| - | TRASTUZUMAB | injection | 78848-006DRUG FOR FURTHER PROCESSING |
| - | TRASTUZUMAB | injection | 78848-007DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing trastuzumab
- Patheon Manufacturing Services LLC19 sites · 319 NDC
- Cephalon, Inc.0 sites · 23 NDC
Enquiry
Common questions
- Is Fareva FDA approved?
- Fareva holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Fareva make?
- 6 products are listed under Fareva in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.